Reset all filters
01 2FOSTAMATINIB DISODIUM
02 1OLUTASIDENIB
03 1PRALSETINIB
Reset all filters
01 4RIGEL PHARMS
Reset all filters
01 2CAPSULE;ORAL
02 2TABLET;ORAL
Reset all filters
01 1100MG
02 1150MG
03 1EQ 100MG BASE
04 1EQ 150MG BASE
Reset all filters
01 4USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : TAVALISSE
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2018-04-17
Application Number : 209299
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : TAVALISSE
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2018-04-17
Application Number : 209299
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : REZLIDHIA
Dosage Strength : 150MG
Packaging :
Approval Date : 2022-12-01
Application Number : 215814
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : GAVRETO
Dosage Strength : 100MG
Packaging :
Approval Date : 2020-09-04
Application Number : 213721
Regulatory Info : RX
Registration Country : USA